Oral glutathione helps maintain high antioxidant levels in the body and alters Melanin formation, shifting darker pigments (Eumelanin) toward lighter pigments (Pheomelanin)

Already in effect (January 1, 2026): Standard PA decisions within 7 calendar days (down from 14) Urgent PA decisions within 72 hours Specific denial reasons required on every denial (not just not medically necessary) Applies to Medicare Advantage, Medicaid managed care, CHIP, and ACA Marketplace plans Coming March 31, 2026: Payers must publicly report PA metrics for calendar year 2025: approval/denial rates, average decision times, and appeals outcomes Providers will be able to compare payer performance for the first time Coming January 1, 2027: FHIR-based Prior Authorization APIs required providers check PA requirements, submit requests, and receive decisions electronically through their EHR Expected to reduce average PA processing time from days to minutes for standard requests Medicare WISeR Model (live in AZ and WA): The Wasteful and Inappropriate Services Reduction pilot launched January 2026 in six states including Arizona and Washington
Biochem., 24(12), 20762084
PMID 15740176
A phase 1 C, open Label, single ascending dose study to evaluate the Safety, Tolerability, and pharmacokinetics of DM199 administered intravenously with a Polyvinyl chloride bag in adult healthy subjects and adults recently taking Angiotensin-Converting enzyme inhibitors
Balance Billing MPC Members is Strictly Prohibited Balance billing MPC members or their family members for any portion of these costs is not acceptable and strictly prohibited